Clinical Trial Update: Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Rocklatan for pressure reduction after MIGS is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

Snippet

Sponsor: Center for Sight Las Vegas | Conditions: Primary Open Angle Glaucoma | Phase 4 | Status: NOT_YET_RECRUITING